|
Unit：
|
Putian Meizhou Bay North Bank Economic Development Zone Management Committee
|
|
|
Project Area：
|
putian-meizhouwanbeian Shanting Town North Bank Management Committee
|
|
|
Industry：
|
Biological and New Pharmaceutical Industry
|
|
|
Type of Project:
|
New Project
|
|
|
Cooperation Mode：
|
Individual Proprietorship,Joint Venture,Collaborate,Land User,Others
|
|
|
Nature of Project：
|
Encourage
|
|
|
Working Progress in Prior Period：
|
In the process of attracting investment
|
|
|
Total Investment：
|
1 million yuan
|
|
|
Expected to Attract Investment：
|
0.8 million yuan
|
|
|
Reason and Condition：
|
The infrastructure of Mazu Health City on the north bank is complete, and the main roads in the core area have been completed and opened to traffic. It has introduced high-end specialized hospitals such as Ruishi Potential Youth Center, Union Medical College Hospital affiliated to Fujian Medical University, Houxin Big Health, Pain Disease Specialized Hospital, forming a "small comprehensive+large specialized+medical technology sharing" model. Putian Lanhai Nuclear medicine Research Center, Southeast Research Institute of Lanzhou University and other projects jointly organized with the Institute of Modern Physics of the Chinese Academy of Sciences have also been launched, which has formed a five in one functional layout of "medical treatment, education, research and development, production, and health care".
|
|
|
Content and Scale：
|
The first phase of the specialized hospital cluster and medical technology sharing center has been built, covering an area of approximately 326 acres and a total construction area of approximately 570000 square meters. It can accommodate no less than 8 hospitals and 3500 beds. Key introduction of clinical specialty hospitals; High end medical technology department; Frontier Diagnosis and Treatment Technology Center; Hospitals, elderly care, and health management institutions; Medical inspection and testing institutions; High level Medical specialty team, etc.
|
|
In 2025, Fujian Province had 341 above-designated-size pharmaceutical enterprises, achieving an operating revenue of RMB 50.28 billion. The province's pharmaceutical industry has cultivated a relatively comprehensive industrial system covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) prepared prescriptions, TCM decoction pieces, and medical devices. During the "14th Five-Year Plan" period, 4 Category-1 innovative drugs and 4 Category-2 innovative drugs were approved, accelerating industrial innovation. Maxim Biotech and Double Medical were promoted as leaders in the industrial chain. 6 projects from 3 enterprises, including Double Medical, were shortlisted for the Ministry of Industry and Information Technology's List of “Open Bidding for Selecting the Best Candidates for Innovation Tasks in Biomedical Materials.” 11 provincial-level industrial leading enterprises in biomedicine, such as Zhangzhou Pien Tze Huang Pharmaceuticals, and 17 enterprises under cultivation for leading status were fostered. 3 enterprises, including AmoyDx, were recognized as national single-item champions (in specific products); 25 enterprises, including Fukang Pharmaceuticals, were recognized as provincial single-item champions (in specific products). 19 pharmaceutical enterprises, including Southern Pharmaceuticals and Fukang Pharmaceuticals, were recognized as National "Little Giants" Enterprises Using Specialized and Advanced Technologies to Create Innovative and Unique Products. 15 enterprises, including Double Medical, Cosunter Pharmaceutical, and Haixi Pharmaceuticals, are listed companies.
- Investment Project for Zherong County Biomedicine Industrial Park
- Investment Project for Zherong County General Health Industrial Park
- Traditional Chinese Medicine Three-industry Integration Industrial Chain Project, Xianyou County, Putian City
- Marine Biomedical Products Project, Marine Life High-tech Industrial Base
- Biomedicine Project, Pingtan Cross-Strait Medical and Health Industrial Park, Haixi (West Coast) Entry-Exit Animal-Plant Quarantine Center, Drug Safety Evaluation Center (Laboratory Animal Center)
- Biology and New Medicine Project, Zherong High-tech Industrial Park
Invest Fujian is a professional website to provide Invest Fujian policy, guide and service for foreign investor.
-
Address：
No. 118 Tongpan Road，Gulou District，Fuzhou，China
-
Tel：
-
Fax：
+86-591-83839780
-
Email：
tczx4@swt.fujian.gov.cn
- Sponsor： Fujian Provincial Department of Commerce
- Organizer： Fujian Investment Promotion Center
- Copyright： Invest Fujian,China 闽ICP备14009608号-12
